NL-OMON42686已完成不适用
A randomized, double-blind, placebo-controlled, single ascending dose and multiple dose study to evaluate the safety, tolerability and pharmacokinetics of Cannabidiol (GWP42003-P) oral liquid formulation with an open label two-period cross-over part to study food effects in healthy subjects - Cannabidiol (GWP42003-P) SAD, FE and MD study
GW Research Ltd.0 个研究点目标入组 56 人开始时间: 待定最近更新:
适应症
试验速览
- 阶段
- 不适用
- 状态
- 已完成
- 发起方
- 入组人数
- 56
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 18 至 99（—）
入选标准
- •- healthy male/ female subjects
- •- 18-45 yrs, inclusive
- •- BMI: 18.0-28.0 kg/m2, inclusive
排除标准
- •Suffering from hepatitis B, hepatitis C, cancer or HIV/AIDS. In case of participation in another drug study within 90 days before the start of this study or being a blood donor within 60 days from the start of the study. In case of donating more than 1.5 liters of blood (for men) / 1.0 liters of blood (for women) in the 10 months prior the start of this study.
研究者
相似试验
未知
Unknown
A single intravenous dose study of E3112 in Japanese healthy adult male subjectsHealthy Adult SubjectsJPRN-jRCT2080223364EA Pharma Co.,Ltd.40
进行中（未招募）
1 期
The pain reduction effects of different doses of Lopain (MTX-071) relative to placebo are evaluated in patients with chronic osteoarthritic knee joint pain.chronic osteoarthritic knee joint painMedDRA version: 21.1Level: LLTClassification code 10023476Term: Knee osteoarthritisSystem Organ Class: 100000004859MedDRA version: 20.0Level: LLTClassification code 10003244Term: Arthritic painsSystem Organ Class: 100000004859MedDRA version: 20.0Level: LLTClassification code 10064238Term: GonalgiaSystem Organ Class: 100000004859EUCTR2018-000818-37-HRMestex AG156
已完成
不适用
Phase I Clinical Study to Evauate the Tolerability and Pharmacokinetics of Belviq in Healthy Korean volunteersKCT0001063Ildong pharmaceutical24
进行中（未招募）
1 期
A trial to evaluate the safety, tolerability, and pharmacokinetics of AQ280 in healthy subjectsAllergic reaction in the gulletDigestive Systemeosinophilic esophagitis (EoE)ISRCTN14453297Aqilion AB64
招募中
不适用
A randomized, double-blind, placebo-controlled, single dose, 3-way cross-over study in healthy elderly subjects to develop an anti-cholinergic pharmacological challenge with biperiden.Alzheimer's diseaseNL-OMON46604Centre for Human Drug Research12